Cardinal Health Raises 2026 Guidance, CAO Exit Puts Focus on Leadership Continuity

Cardinal Health raises its fiscal 2026 earnings guidance and emphasizes growth in its pharmaceutical and specialty platforms. The company's leadership continuity has been emphasized with the planned retirement of Chief Accounting Officer Mary Scherer in February 2027. The key short-term catalyst remains execution against the upgraded fiscal 2026 EPS guidance. Investors should be aware of heavy reliance on major customer contracts that could affect future earnings power.